Get the Stockscreener App
99.78
1.05%
-1.11
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $99.78, with a volume of 4.61M.
It is down -1.05% in the last 24 hours and up +18.30% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$100.89
Open:
$101.4
24h Volume:
4.61M
Relative Volume:
0.36
Market Cap:
$247.76B
Revenue:
$63.90B
Net Income/Loss:
$19.05B
P/E Ratio:
13.20
EPS:
7.5596
Net Cash Flow:
$13.05B
1W Performance:
-4.77%
1M Performance:
+18.30%
6M Performance:
+28.61%
1Y Performance:
-3.59%
1-Day Range:
$99.73
$102.09
1-Week Range:
$99.73
$105.68
52-Week Range:
$73.31
$105.84
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
99.82 | 250.41B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,011.04 | 907.99B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
202.13 | 487.83B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
225.81 | 404.22B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
132.89 | 254.11B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Automated Pharmacy Compounding Systems Market Growing Toward USD 5.27 Billion in 2035 - GlobeNewswire Inc.
Trek Financial LLC Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
M Holdings Securities Inc. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kennedy Capital Management LLC - MarketBeat
Guggenheim Adjusts Price Target on Merck & Co. to $122 From $104, Maintains Buy Rating - marketscreener.com
Amundi Buys 3,454,941 Shares of Merck & Co., Inc. $MRK - MarketBeat
Beutel Goodman & Co Ltd. Acquires 679,339 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.4%What's Next? - MarketBeat
Merck & Co. Closes $7 Billion Notes Offering - TipRanks
Merck & Co., Inc. (MRK) Stock: Gains FDA Nod for New Cattle Antiparasitic - CoinCentral
Scotiabank Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment - pharmiweb.com
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Merck (NYSE: MRK) gets FDA conditional OK for EXZOLT CATTLE-CA1 vs New World screwworm - Stock Titan
Scotiabank Adjusts Price Target on Merck & Co to $120 From $105, Maintains Sector Outperform Rating - marketscreener.com
Merck & Co., Inc. $MRK Shares Bought by Guggenheim Capital LLC - MarketBeat
First Trust Advisors LP Has $399.74 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
CW Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Baird Financial Group Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Up 1.3% on Analyst Upgrade - MarketBeat
Analysts Conflicted on These Healthcare Names: Merck & Company (MRK), Alibaba Health Information Technology (OtherALBHF) and Janux Therapeutics Inc (JANX) - The Globe and Mail
River Wealth Advisors LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Invesco Ltd. Has $1.35 Billion Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck (MRK) Stock on December 2, 2025: Dividend Hike, FDA Wins and Fresh Wall Street Targets - ts2.tech
The Goldman Sachs Group Boosts Merck & Co., Inc. (NYSE:MRK) Price Target to $120.00 - MarketBeat
Transcript : Merck & Co., Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 09 - marketscreener.com
Westerkirk Capital Inc. Makes New $2.64 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Isthmus Partners LLC Makes New $1.03 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Sio Capital Management LLC Has $13.77 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
M&T Bank Corp Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Files For Seven- Part Notes Offering Of Up To $7.5 Billion- SEC Filing - TradingView
Merck & Co., Inc. (NYSE:MRK) Shares Down Following Recent Session Drop - Kalkine Media
Merck & Co., Inc. $MRK Shares Acquired by Arrowstreet Capital Limited Partnership - MarketBeat
Merck Wants Fed. Circ. Redo On Decision Backing Axed IP - Law360
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 2.9%Here's Why - MarketBeat
Merck Kicks Off US Dollar Bond Sale to Help Fund Cidara Deal - Bloomberg.com
A Look Into Merck & Co Inc's Price Over Earnings - Benzinga
Merck seeks up to US$8 bil in US bond sale tied to Cidara deal — Bloomberg - The Edge Malaysia
VestGen Advisors LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Form 424B5 Merck & Co., Inc. - StreetInsider
Merck Showcases Data For Alzheimer's Disease Candidates Mk-2214 And Mk-1167 At Ctad 2025 - TradingView
OMERS ADMINISTRATION Corp Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
TradeLink Capital LLC Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Shelton Capital Management Acquires 22,024 Shares of Merck & Co., Inc. $MRK - MarketBeat
Legacy Capital Wealth Partners LLC Has $314,000 Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck (NYSE: MRK) gets FDA Fast Track for MK-2214, shares human Alzheimer’s data at CTAD - Stock Titan
Loomis Sayles & Co. L P Has $18.33 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Quadrature Capital Ltd Trims Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Lessened by Northwestern Mutual Wealth Management Co. - MarketBeat
Distillate Capital Partners LLC Sells 58,061 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fisher Asset Management LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
2.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):